Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 4Stomatitis 3Squamous Cell Carcinoma of Head and Neck 3Laryngeal Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Squamous Intraepithelial Lesions 2Skin Neoplasms 2Hematologic Neoplasms 2Dyspareunia 2Carcinoma, Hepatocellular 2Carcinoma, Basal Cell 2Warts 1Vulvar Neoplasms 1Vomiting 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Soft Tissue Neoplasms 1Retinoblastoma 1Radiodermatitis 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Papillomavirus Infections 1Papilloma 1Pain 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Microsurgery 1Lasers, Gas 1Laser Therapy 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal papillomatosis × Laser Therapy × Clear all
NCT00592319 2012-08-31

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Boston University

Phase 2 Terminated
10 enrolled 6 charts
Head & Neck

Laryngeal papillomatosis, Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡